Video

Latest research supporting stereotactic radiotherapy for oligometastatic renal cell carcinoma

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      At the SUO 23rd Annual Meeting, Raquibul Hannan, MD, PhD, the latest research findings showing positive results with stereotactic radiotherapy in patients with oligometastatic renal cell carcinoma. Hannan is a professor in the Department of Radiation Oncology, Urology and Immunology at the University of Texas Southwestern Medical Center in Dallas.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      © 2025 MJH Life Sciences

      All rights reserved.